# Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity

> **NCT01017263** · PHASE4 · TERMINATED · sponsor: **Duke University** · enrollment: 14 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder
- Glucose Intolerance
- Obesity

## Interventions

- **DRUG:** Lis-dexamphetamine

## Key facts

- **NCT ID:** NCT01017263
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Due very high screen fail rate, pre study feasibility not consistent with screened population.
- **Last updated:** 2014-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01017263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01017263, "Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01017263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*